Back to News
Dec 24, 2025 12:00 AM

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?

Indaptus Therapeutics Inc. (NASDAQ:INDP) jumped 64.65% to $3.26 in after-hours trading on Tuesday.

Check out the current price of INDP stock here. 

Indaptus disclosed in a Form 8-K filing, which is used to report significant unscheduled corporate changes, that investor David E. Lazar purchased 300,000 shares of Series AA Preferred Stock and 700,000 shares of Series AAA Preferred Stock at $6.00 per share on Monday, generating aggregate gross proceeds of $6 million.

The preferred shares are convertible into 111 million shares of common stock, subject to stockholder approval.

Board Restructuring Completed

The Board also appointed Lazar as Co-Chief Executive Officer.

Lazar currently serves as the CEO and Chairman of Kala Bio Inc. (NASDAQ:KALA). David previously served as Chief Executive Officer of Novabay Pharmaceuticals, Inc.